Pricing Log in Create free account

BioNTech SE Sponsored ADR (BNTX) vs Roivant Sciences Ltd. (ROIV)

BioNTech SE Sponsored ADR and Roivant Sciences Ltd. are both Biotechnology companies. Roivant Sciences Ltd. is the larger, with a market value of $26.5B against $21.6B — 1.2× the size. BioNTech SE Sponsored ADR grew revenue faster over the last twelve months: −22.7% against −67.6%. BioNTech SE Sponsored ADR has the higher net margin (−63.8% vs −3,535.0%) and the higher return on invested capital (−34.3% vs −34.5%). Across the 18 metrics below, BioNTech SE Sponsored ADR leads on 11 and Roivant Sciences Ltd. on 7.

Valuation

Metric BNTX ROIV Biotechnology median
P/E n/m n/m 10.26
P/S 7.88 3,528.29 9.18
P/B 1.05 5.40 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1.84 3,061.16 8.98
Earnings yield (7.93%) (1.03%) (34.89%)
Free cash flow yield (2.44%) (3.09%) (24.52%)

Profitability

Metric BNTX ROIV Biotechnology median
Gross margin 74.59% 81.21% 65.16%
Operating margin (78.99%) (7,914.75%) 0.00%
Net margin (63.77%) (3,534.96%) 0.00%
Free cash flow margin (19.21%) (10,901.00%) 0.00%
Return on equity (8.29%) (5.47%) (50.12%)
Return on assets (7.22%) (5.15%) (45.60%)
Return on invested capital (34.28%) (34.51%) 0.00%

Growth

Metric BNTX ROIV Biotechnology median
Revenue growth (TTM) (22.73%) (67.58%) 6.26%
EPS growth (last fiscal year) (77.33%) (125.00%) 29.88%
Revenue growth, 5-year CAGR 42.58% (19.07%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX ROIV Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 8.55 16.72 4.89
Net debt to EBITDA 14.29 8.39 1.01

Dividend

Metric BNTX ROIV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BNTX ROIV Biotechnology median
Market cap 21.57b 26.45b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack